[Antithrombotic Action of Alcohol in Relation to Platelet Function].
Level 5 - mechanism / opinion, no new human data
Narrative review describing biological mechanisms without systematic search methods or primary clinical data.
PubMed 39631877 · doi:10.1265/jjh.24007
What was done
Narrative review describing the biological mechanisms underlying the antithrombotic and platelet-inhibitory actions of alcohol and red wine components.
What was found
The abstract provides no quantitative data or effect sizes. It reports that ethanol inhibits capacitative Ca2+ entry, plasmalemmal phospholipase A2 activity, and thromboxane A2 production. Resveratrol in red wine also inhibits capacitative Ca2+ entry and works synergistically with ethanol to inhibit platelet aggregation by reducing contractile apparatus Ca2+ sensitivity and attenuating COX-1 activity. Alcohol intake also reduces coagulation factors including fibrinogen, conferring both an antithrombotic effect and a hemorrhagic diathesis.
Why it matters
Synthesizes proposed cellular pathways that may explain observed associations between light alcohol consumption and reduced ischemic cardiovascular disease.
Limits
Narrative mechanism review with no systematic search criteria, human trials, or quantitative clinical outcomes presented in the abstract. Confounding factors in observational alcohol research and bleeding risks are not quantitatively addressed.
Cited by
- supports Alcohol reduces platelet aggregation, making platelets less likely to form clots.